Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
10R)-2-[(2S
inhibits prostate cancer cell growth in vitro and tumor growth in vivo
InChi: InChI=1S/C15H9Br2NO3/c16-8-1-2-12-9(6-8)10(15(21)18-12)3-7-4-11(17)14(20)13(19)5-7/h1-6
EXP3174 inhibits the angiotensin II-induced cell protein synthesis with an IC50 of 3 nM
(2002) Blood
ENMD-2076 ohesperidin dihydrochalcone 10R)-2-[(2SENMD 2076 is an orally active, Aurora A angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. ENMD 2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase. Aurora kinases are key regulators of mitosis (cell division), and are often over expressed in human cancers. ENMD 2076 also targets the VEGFR, Flt 3 and FGFR3 kinases which have been
US$ 20.02
US$ 52.00
US$ 20.00
US$ 17.00